DRTS
Alpha Tau Medical·NASDAQ
--
--(--)
--
--(--)
7.47 / 10
Outperform
Sentiment is strong (7.47/10) with a 75% Strong‑Buy consensus and positive small‑cap inflows (score 7.41). Overall fund flow is good despite a negative trend in larger blocks. Analyst confidence is high, yet the stock price fell 5.4%.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
75%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-03-04
InstitutionPiper Sandler
Times predicted1
Historical Win Rate100.0%
What is the analyst consensus for DRTS?
- DRTS holds a Bullish analyst rating, with 75% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 7.47/10 (Outperform).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
